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Actionable Patient Safety Solutions (APSS) #3A: 
Medication errors
How to use this guide
This guide gives actions and resources for creating and sustaining safe 
practices for reducing medication errors. In it, you’ll find:
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APSS #3A: Medication errors
Executive summary checklist
Medication errors are major causes of inpatient harm and death. Medication errors are 
preventable adverse events due to wrong medicine use including:
• Wrong medicine
• Wrong dose
• Wrong route
• Wrong time
• Wrong patient
• Wrong documentation of medicine
Ensure best patient care
  Create a multidisciplinary team to lead the project, including physicians, nurses, 
pharmacists, and information technology personnel
  Use systematic protocols for medicine administration, including checklists for writing and 
filling prescriptions, drug administration and patient transitions of care, and other quality 
assurance tools including:
  Install the latest safety technology to prevent medication errors, such as:
  The BD Intelliport Medication Management System
  First Databank FDB MedKnowledge drug library system 
  Other drug dosing solutions such as Monarch Medical Technologies solution for 
calculating IV & SubQ insulin doses
  Use barcoding for identification in the medicine administration process
  Check patient’s allergy profile before prescribing medicine
  Ensure appropriate training and safe operation of automated infusion technologies
  Distinguish “look-alike, sound-alike” medicines by labeling, package design, and 
storage
  Practice the Six Patient Rights on Medications - all care providers should use this simple 
checklist: right patient, drug, dose, route, time of administration, and documentation
  Follow practices to prevent medication errors during Transitions of Care
Engage staff and use data to find areas for improvement
  Use technology to standardize Computerized Physician Order Entry (CPOE), reporting 
systems and quality assurance reports to audit compliance
  Use Clinical Decision Support Systems (CDSS) where possible (Kane-Gill et al., 2017)
  Review monitoring and reporting results at medical staff meetings and education 
sessions as a part of Continuous Quality Improvement (CQI)
  Use patient stories - in written and video form - to identify gaps and inspire change in 
your staff
2 | APSS #3A
What we know about medication errors
Medication errors are a major cause of death. One out 
of every 2 surgeries has a medication error or an ad-
verse drug event (Nanji et al., 2016). These errors have 
a global cost of about $42 billion a year (Donaldson et 
al., 2017). 
Addressing medical errors can improve the quality 
and safety of healthcare and lower costs. It also helps 
create a safety culture, which is a culture that promotes 
patient safety and quality of care while reducing pre-
ventable risks and harm. 
Some types of medication errors are more common or 
severe. For example:
• Drug infusion pump errors are common and may 
have serious consequences. Drug infusion pumps are 
complex and have poorly designed features for the 
user, which make it difficult for the user to program 
and use. Patients who get infused medicines are often 
critically ill and taking multiple medicines, which fur-
ther increases the chance of error and adverse events. 
• Surgery has high rates of medication errors with a 
higher severity level (NQF, 2010). This is due to a high-
stress en
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Medication errors are a major cause of death. One out of every 2 surgeries has a medication 
error or an adverse drug event (Nanji et al., 2016). These errors have a global cost of about $42 
billion a year (Donaldson et al., 2017). 
Addressing medical errors can improve the quality and safety of healthcare and lower costs. It 
also helps create a safety culture, which is a culture that promotes patient safety and quality of 
care while reducing preventable risks and harm. 
Some types of medication errors are more common or severe. For example:
• Drug infusion pump errors are common and may have serious consequences. Drug 
infusion pumps ar  complex and have poorly designed features for the user, which make 
it difficult for the user to program and use. Patients who get infused medicines are often 
critically ill and taking multiple medicines, which further increases the chance of error 
and adverse events. 
• Surgery has high rates of medication errors with a higher severity level (NQF, 2010). This 
is due to a high-stress environment and lack of computeriz d order entry, pharmacy 
approval, or second check by another person prior to giving the medicine.  
Preventing medication errors
To reduce medication errors, there are a variety of new approaches that hospitals and 
healthcare systems can commit to using, such as automated infusion and IV injectable 
technologies, electronic medical records, and checklists.
Leadership plan
Hospital governance, senior administrative leadership, clinical leadership, and safety/risk 
management leadership need to work collaboratively to reduce medication errors.
Show leadership’s commitment 
• Create a medicine safety plan that follows the National Quality Forum (NQF) safe 
practices (NQF, 2010)
• Educate and empower patients, healthcare professionals, researchers, and insurers
o Provide information so t at lead rship and all healthcare professionals fully 
understand the performance gaps in their own area of care
o Make sure all clinical/safety leadership endorse the plan to ensure it’s put into place 
across all providers and systems
Create the infrastructure needed to make changes
• Identify approaches to medication safety that:
o Have strong evidence that they work to reduce preventable deaths
o Can be applied in multiple care settings and for multiple patient types
• Set a firm date to begin the safety plan, with measurable outcomes and milestones - 
“Some is not a number. Soon is not a time.” (IHI, n.d.)
• Get approval for the plan’s budget from governance boards and leadership
• Use a standardized feedback system to fine-tune the plan over time
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Engage staff
• Use patient stories – in written and video form – to teach and inspire change in your staff
• For example, the story of Emily Jerry, daughter of Chris Jerry, is one of many compelling 
stories that can be viewed and shared for free: 
 https://youtu.be/9jmULQ_m04o 
Action plan
Provide staff training
• Create a multidisciplinary team that includes physicians, nurses, pharmacists, and 
information technology personnel
• Assess opportunities to reduce medication errors using a self-assessment process (ISMP, 
2011)
• Create and deliver monthly or quarterly education on medication error and patient 
safety updates
Create protocols
• Create a universal checklist for medicine administration that includes: 
o Patient name
o List of patient’s current medicines
o Medicine to be given and its:
• Dose
• Route
• Timing
• Documentation
• Systematize tools and practices, including checklists, for:
o Patient allergy and medicine interaction checks on every patient
o CPOE (Computerized physician order entry)
o Medicine barcoding
o Patient education and adherence 
o Correct and on-time medication administration (ISMP, 2011)
• Practice hand hygiene when giving medicine as tablets, capsules, and pills by hand, such 
as wearing gloves instead of bare hands
• Use standardized order sets where possible
• Review medicine labels and redesign as needed (Practices, n.d.)
• Prepare medicine in separate, designated rooms to lower interruptions (Huckels-
Baumgart et al., 2016)
Follow guidelines and regulations
• Follow the Institute for Safe Medication Processes (ISMP) guidelines for
o Training and safe use of intravenous infusion pumps
o Use of medicine dispensing cabinets (ISMP, 2011)
o Adult IV Push Medications
o High-Alert Medications
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• Ensure that all FDA and USP regulations are met and followed by either in-house 
production or third party vendor as part of a standardized process for compounding 
sterile medicines (Practices, n.d.)
• Follow the APSS#4 guidelines for continuous monitoring of all patients who are receiving 
parenteral narcotics or other sedative drugs
• Practice CDC Guidelines for single use injections -  one solution, one patient, one syringe
• Use FDA Manufactured Single Use Injection Kits (SUIK) when available
Ensure safety during transitions of care
• Consider the following high-risk medicine groups:
1. Opioids
a. Consider all pain medicines including over the counter
b. Concern for over-using tylenol
2.  Anti-diabetics
a.  Resume Metformin, confirm kidney function appropriate
b.  Adjust insulin based on food intake
3.  Anticoagulation/Antiplatelet
a. INR levels, renal function, OTC medicine use (NSAIDs)
4.  Antibiotics
a. Appropriate duration of therapy
b.  Labs ordered (vancomycin follow up)
c.  Home health ordered
• Coordinate appropriate follow up and monitoring, such as:
o Labs: INR, Digoxin levels, electrolytes, blood sugar, vancomycin troughs, thyroid 
levels
o Chronic disease state management, such as heart failure, asthma, and COPD
• Confirm medicine dose for any changes in health status, including changes in:
o Weight
o Renal and liver function
o Functions that could affect the patient’s ability to take medicine by mouth, injection, 
or inhalation
• Confirm needed medical equipment is ordered, such as a nebulizer, diabetic supplies, 
and IV antibiotic
• Evaluate for high risk disease states
o Check patients comply with core measures and immunizations when appropriate 
(Stroke, MI, Heart Failure)
o Ensure patients receive and are educated on scheduled vaccines (influenza, 
pneumonia, etc)
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Technology plan
These suggested practices and technologies have shown proven benefit or, in some cases, 
are the only known technologies for certain tasks. If you know of other options not listed here, 
please complete the form for the PSMF Technology Vetting Workgroup to consider: 
https://patientsafetymovement.org/actionable-solutions/apss-workgroups/technology-
vetting/
System or practice Available technology
All settings
ONC Meaningful Use Cert ified EHR system 
Electronic Health Record (EHR) System with 
the following capabilities:
•	 Computerized Physician Order Entry 
(CPOE)
•	 Drug-drug interaction check
•	 Drug-allergy interaction check
•	 Electronic Prescribing (eRx)
•	 Electronic Prior Authorization (ePA)
Electronic Medication Administration Record 
(eMAR) system with pharmacy and bedside 
barcoding capabilities
First Databank FDB MedKnowledge system 
(First Databank, 2014)
FDA approved clinical decision support 
solution for medication therapy 
recommendation
Monarch Medical Technologies* Endotool 
Solutions for insulin
Infusion pumps that wirelessly communicate 
data back to the electronic eMAR
Patient and medication barcoding system
CPOE simulation tool to quantify the risk of 
serious ADEs with your current system CPOE 
(Metzger et al., 2010; Leung et al., 2013)
Leapfrog CPOE Evaluation Tool (Leapfrog, 
2016)
Drug libraries
Pharmacy workflow manager DoseEdge from Baxter Healthcare
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Surgery environment
IV injectable doses, audible and visual 
feedback for each syringe attached with 
measurement of dose, allergy alerts and more 
accurate and timely documentation wireless 
to the anesthesia information system
BD Intelliport* Medication Management 
System.
Continuous physiologic monitoring on 
patients receiving IV medications to provide 
an early indication of deterioration due to a 
medication error
Masimo* rainbow Acoustic Monitoring 
(Mimoz et al., 2012)
Pharmacy 
Pharmacy robots to reduce safety problems 
associated with providers drawing up their 
own medications, and risks associated 
with contamination from outsourced 
compounders
BAXA Intellifil Robot
Utilize single use injection kits or pre-mixed 
sterile solutions
• Asclemed USA Inc., Injection Kits
• Nubratori RX, Pre-mixed sterile solutions
Other considerations
“End-to-end” smart pump system, or other electronic pump systems
*Company has signed some form of the Open Data Pledge, more information can be found on 
the Patient Safety Movement Foundation website: https://patientsafetymovement.org/partners/
open-data-pledges/view-all-open-data- pledges/
Measuring outcomes
Key performance indicators
Adverse drug event: Adverse drug event (ADE) with harm to patient (Category E or higher 
on NCC-MERP classification) that is preventable (i.e., not an unknown first-time reaction to a 
medicine).
Outcome measure formula
Numerator: Number of reported adverse drug events with harm (as defined above) – by class 
or medication
Denominator: Number of doses administered (by medicine or class of medicines)
*Rate is typically displayed as ADE with harm/1000 doses given
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Metric recommendations
Indirect impact (preventable rate): All patients 
Direct impact (non-preventable rate): All patients prescribed medicines
Lives spared harm:
Lives Spared Harm = (ADE Rate baseline - ADE Rate measurement ) X Doses or Adjusted Patient Days 
baseline
Lives saved:
Lives Saved = Lives Spared Harm x Mortality Rate
Notes
Top medicine classes and triggers:
1. Opioids
2. Sedatives and hypnotics (including propofol)
3. Anticoagulants
4. Antimicrobials (including antivirals and antifungals)
5. Anti-diabetic medicines (including insulin, and other injectable and oral medicines)
6. Injectable medicines
Initial or baseline measurement will show ability to capture ADE information, since most 
are voluntarily reported. Over time, decreases in this rate can show lives spared harm. To 
ensure that reductions are not due to decreased reporting, a control measure should also be 
measured:
Control rate calculation
Numerator: Number of ALL reported errors and adverse drug reactions (including harm and 
NOT causing harm or “near misses”)
Denominator: Number of doses administered over time period
Control ADE rate should be consistent or increase, with corresponding decrease in ADE with 
harm.
Data collection
ADE reporting information is based on volunteer reporting and accuracy of people verifying 
reports (preferably from pharmacy and a medication errors reporting program, MERP).
Medicine usage information is usually collected from billing information rather than medicine 
orders (more accurate if patient received the dose or not).
If medicine usage information is not available, denominator could be per 1000 patient days. 
This can track over time, especially for all ADE reporting, however, will not adjust ADE rate for 
high or low utilization medications.
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Scales
• The Adverse Drug Reaction Probability Scale (Naranjo) determines the causality of an 
ADR or how likely is the drug the true cause of the ADE (NLM, 2015)
Mortality (will be calculated by the Patient Safety Movement Foundation)
The PSMF, when available, will use the mortality rates associated with Hospital Acquired 
Conditions targeted in the Partnership for Patients (PfP) grant funded Hospital Engagement 
Networks (HEN). 
The program targeted 10 hospital acquired conditions to reduce medical harm and costs of 
care. “At the outset of the PfP initiative, HHS agencies contributed their expertise to developing 
a measurement strategy to track national progress in patient safety—both in general and 
specifically related to the preventable HACs being addressed by the PfP. Along with CMS’s 
overall leadership of the PfP, AHRQ has helped coordinate development and use of the 
national measurement strategy. The results using this national measurement strategy have been 
referred to as the “AHRQ National Scorecard,” which provides summary data on the national 
HAC rate (AHRQ, 2015). Adverse drug events was included in this work with published metric 
specifications. This is the most current and comprehensive study to date. 
Based on these data the estimated additional inpatient mortality for Adverse Drug Events is 
0.020 (20 per 1000 events).
Conflicts of interest disclosure
The Patient Safety Movement Foundation partners with as many stakeholders as possible to 
focus on how to address patient safety challenges. The recommendations in the APSS are 
developed by workgroups that may include patient safety experts, healthcare technology 
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Some of the APSS recommend technologies offered by companies involved in the Patient 
Safety Movement Foundation that the workgroups have concluded, based on available 
evidence, that these technologies work to address APSS patient safety issues. Workgroup 
members are required to disclose any potential conflicts of interest.
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